Mitogen stimulation of blood lymphocytes from patients with primary intracranial tumors. Correlation to histological tumor type.
Blood lymphocytes from 125 patients with primary intracranial tumors were examined for proliferative responses to PHA and PPD in parallel with lymphocytes from sex- and age-matched controls. The tests were performed prior to surgery, radiotherapy, or chemotherapy and a histological diagnosis was obtained in all cases. Depending on tumor type, patients were divided into the following four histological groups: astrocytomas, oligodendrogliomas, malignant gliomas (anaplastic astrocytomas and glioblastomas), and miscellaneous tumors (mainly meningiomas). PHA-responses were approximately 10% lower in patients with malignant gliomas not receiving corticosteroids in comparison to corresponding controls. No significant differences were observed in the other groups of patients if not being treated with steroids. PPD-responses were largely similar in all groups of non-steroid treated patients. In the corticosteroid treated groups PHA-responses were significantly reduced in patients with oligodendrogliomas and malignant gliomas, but this was not true of those with astrocytomas or those in the group with miscellaneous tumors. The mean steroid doses given at the time of testing were similar in all four patient groups. The treatment period was longest in malignant gliomas but reasonably similar in the other three groups. It is speculated that PHA-responses of lymphocytes from patients with oligodendrogliomas may exhibit an increased steroid sensitivity.
D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D000328:Adult; D000368:Aged; D001254:Astrocytoma / Q000276:immunology; D001932:Brain Neoplasms / Q000276:immunology* / Q000473:pathology; D005260:Female; D005910:Glioma / Q000276:immunology; D006801:Humans; D007958:Leukocyte Count; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D008579:Meningioma / Q000276:immunology; D008875:Middle Aged; D008934:Mitogens / Q000494:pharmacology; D009837:Oligodendroglioma / Q000276:immunology; D010835:Phytohemagglutinins / Q000494:pharmacology; D014373:Tuberculin / Q000494:pharmacology
D000305:Adrenal Cortex Hormones; D008934:Mitogens; D010835:Phytohemagglutinins; D014373:Tuberculin